Covered recipient · General Payments record
TAMMY ANN NORCIA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$635.95
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.87 | 14 |
| Education | $13.89 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $78.80 | 5 |
| Amgen Inc. | $45.10 | 3 |
| GlaxoSmithKline, LLC. | $41.99 | 2 |
| Nevro Corp. | $24.74 | 1 |
| Abbott Laboratories | $18.25 | 1 |
| Astellas Pharma US Inc | $18.15 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.50 | 1 |
| Esperion Therapeutics, Inc. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.25 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125319597 | CMS |
| Amgen Inc. | $16.48 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117642843 | CMS |
| Amgen Inc. | $14.73 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340805 | CMS |
| Amgen Inc. | $13.89 | 10/01/2024 | Education | Undisputed | 01/23/2026 | 1117642845 | CMS |
| Astellas Pharma US Inc | $18.15 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139503515 | CMS |
| Esperion Therapeutics, Inc. | $14.23 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129473326 | CMS |
| GlaxoSmithKline, LLC. | $19.86 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580495 | CMS |
| GlaxoSmithKline, LLC. | $22.13 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116260850 | CMS |
| Lilly USA, LLC | $20.06 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135870103 | CMS |
| Lilly USA, LLC | $13.63 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135961947 | CMS |
| Lilly USA, LLC | $15.28 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135919532 | CMS |
| Lilly USA, LLC | $14.50 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893937 | CMS |
| Lilly USA, LLC | $15.33 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135870107 | CMS |
| Nevro Corp. | $24.74 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766833 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.50 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153423238 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.